2000
DOI: 10.1016/s0003-4975(00)01812-9
|View full text |Cite
|
Sign up to set email alerts
|

Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
68
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 110 publications
(68 citation statements)
references
References 18 publications
0
68
0
Order By: Relevance
“…It has become increasingly clear that the assumption that xenoantigens are likely to be cell-associated is not valid. Our findings further emphasize that treatment of unfixed xenogeneic tissues for tissue engineering applications must shift from a paradigm of "decellularization" to one of "antigen removal" [9][10][11][12][14][15][16][17][18][19][20][21][22][23][24][25][26]. Current or future antigen removal or antigen masking treatments will need to account for both cellular and extracellular matrix antigens.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It has become increasingly clear that the assumption that xenoantigens are likely to be cell-associated is not valid. Our findings further emphasize that treatment of unfixed xenogeneic tissues for tissue engineering applications must shift from a paradigm of "decellularization" to one of "antigen removal" [9][10][11][12][14][15][16][17][18][19][20][21][22][23][24][25][26]. Current or future antigen removal or antigen masking treatments will need to account for both cellular and extracellular matrix antigens.…”
Section: Discussionmentioning
confidence: 99%
“…Because tissues are unfixed in this application, it is necessary to remove graft antigenicity prior to implantation. Numerous physical and chemical treatments designed to decrease the immunogenicity of unfixed xenogeneic biomaterials have been investigated [9,11,12,[14][15][16][17][18][19][20][21][22][23][24][25][26]. These treatments have generally been characterized as tissue "decellularization", based on the assumption that antigens mediating an immune response to the graft would likely be cell-associated.…”
Section: Introductionmentioning
confidence: 99%
“…This has been recognized as the FDA-recommended animal model for testing new designs of mechanical valves, tissue-based bioprosthetic valves, cryopreserved homografts and biohybrid devices (6,20,(23)(24)(25)(26)(27)(28). Although not initially developed for tissue engineering, sheep implantation continues to be the animal model of choice for testing of acellular valve scaffolds (29)(30)(31)(32)(33)(34). The juvenile sheep model is accessible, reproducible, accelerates valve calcification and approximates the human anatomy.…”
Section: Acellular Scaffolds and Their Behavior In Vivomentioning
confidence: 99%
“…Several authors have developed decellularization techniques followed by in vitro reseeding with autologous cells (Cebotari et al, 2000;Steinhoff et al, 2000) or allowing ingrowth of host cells into the graft after transplantation (Wilson et al, 1995;Goldstein et al, 2000;Steinhoff et al, 2000;Dohmen et al, 2002). In the case of arteries, the acellular matrix is composed of insoluble collagen, elastin, and glycosaminoglycans from the original vessel.…”
mentioning
confidence: 99%